Neuroligin-3 and neuroligin-4X form nanoscopic clusters and regulate growth cone organization and size.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
03 03 2022
Historique:
received: 20 07 2021
revised: 25 08 2021
accepted: 13 09 2021
pubmed: 21 9 2021
medline: 28 4 2022
entrez: 20 9 2021
Statut: ppublish

Résumé

The cell-adhesion proteins neuroligin-3 and neuroligin-4X (NLGN3/4X) have well described roles in synapse formation. NLGN3/4X are also expressed highly during neurodevelopment. However, the role these proteins play during this period is unknown. Here we show that NLGN3/4X localized to the leading edge of growth cones where it promoted neuritogenesis in immature human neurons. Super-resolution microscopy revealed that NLGN3/4X clustering induced growth cone enlargement and influenced actin filament organization. Critically, these morphological effects were not induced by autism spectrum disorder (ASD)-associated NLGN3/4X variants. Finally, actin regulators p21-activated kinase 1 and cofilin were found to be activated by NLGN3/4X and involved in mediating the effects of these adhesion proteins on actin filaments, growth cones and neuritogenesis. These data reveal a novel role for NLGN3 and NLGN4X in the development of neuronal architecture, which may be altered in the presence of ASD-associated variants.

Identifiants

pubmed: 34542148
pii: 6372551
doi: 10.1093/hmg/ddab277
pmc: PMC8895740
doi:

Substances chimiques

Cell Adhesion Molecules, Neuronal 0
Membrane Proteins 0
Nerve Tissue Proteins 0
neuroligin 3 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

674-691

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N026063/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 097819
Pays : United Kingdom

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press.

Références

Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):6997-7002
pubmed: 26038554
Exp Neurol. 2006 May;199(1):143-55
pubmed: 16464451
Nat Rev Neurosci. 2007 Mar;8(3):194-205
pubmed: 17311006
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7568-73
pubmed: 20368431
Neuron. 2010 Sep 23;67(6):967-83
pubmed: 20869594
Neurosci Lett. 2006 Mar 6;395(2):114-7
pubmed: 16300891
Nature. 2018 Jan 10;553(7687):165-170
pubmed: 29323291
Mol Psychiatry. 2012 Jan;17(1):71-84
pubmed: 21606927
Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5671-6
pubmed: 23509247
Mol Cell. 2018 Apr 5;70(1):106-119.e10
pubmed: 29625032
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3053-8
pubmed: 21282647
Nat Rev Mol Cell Biol. 2009 May;10(5):332-43
pubmed: 19373241
J Cell Biol. 2019 Aug 5;218(8):2677-2698
pubmed: 31262725
Mol Cell Neurosci. 2018 Sep;91:95-107
pubmed: 29673914
Nat Genet. 2014 Aug;46(8):881-5
pubmed: 25038753
Mol Psychiatry. 2016 Feb;21(2):169-77
pubmed: 25778475
Stem Cell Res Ther. 2015 Aug 22;6:149
pubmed: 26296747
Elife. 2018 Jul 25;7:
pubmed: 30044218
Cell. 2012 Nov 9;151(4):709-723
pubmed: 23141534
J Biol Chem. 2003 May 23;278(21):19220-9
pubmed: 12626503
Neuroscience. 2010 Feb 3;165(3):782-93
pubmed: 19914352
Int J Dev Biol. 2002;46(4):649-52
pubmed: 12141453
J Biol Chem. 2011 Jan 7;286(1):851-8
pubmed: 21056983
Mol Psychiatry. 2018 Mar;23(3):735-746
pubmed: 28948968
Neuron. 2007 Jun 21;54(6):919-31
pubmed: 17582332
Nat Protoc. 2014 Feb;9(2):457-63
pubmed: 24481272
Cold Spring Harb Perspect Biol. 2010 Apr;2(4):a001925
pubmed: 20452947
Nat Neurosci. 2009 Oct;12(10):1275-84
pubmed: 19734897
Biol Psychiatry. 2017 Jul 1;82(1):49-61
pubmed: 27837918
Cell. 2004 Dec 29;119(7):1013-26
pubmed: 15620359
Nat Neurosci. 2019 Feb;22(2):243-255
pubmed: 30617258
J Neurochem. 2016 Apr;137(1):26-32
pubmed: 26725465
J Cell Biol. 2016 Feb 15;212(4):449-63
pubmed: 26880202
Dev Cell. 2007 Nov;13(5):646-662
pubmed: 17981134
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
J Neurosci. 2013 Oct 2;33(40):15767-78
pubmed: 24089484
Elife. 2018 Mar 05;7:
pubmed: 29504935
Neuron. 2012 Mar 22;73(6):1068-81
pubmed: 22445336
Nat Commun. 2018 Sep 28;9(1):3979
pubmed: 30266896
Nature. 2014 Apr 10;508(7495):199-206
pubmed: 24695229
Nat Rev Neurosci. 2008 Feb;9(2):136-47
pubmed: 18209731
Small GTPases. 2014;5:
pubmed: 24658305
Science. 2007 Oct 5;318(5847):71-6
pubmed: 17823315
Neuron. 2006 Sep 21;51(6):741-54
pubmed: 16982420
Nat Cell Biol. 2002 Sep;4(9):681-90
pubmed: 12198493
PLoS Biol. 2012;10(6):e1001350
pubmed: 22745599
Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6421-6
pubmed: 18434543
Cytometry A. 2004 Apr;58(2):167-76
pubmed: 15057970
Database (Oxford). 2016 Feb 20;2016:
pubmed: 26896845
Cereb Cortex. 2017 Jan 1;27(1):216-232
pubmed: 28013231
Nature. 2008 Oct 16;455(7215):903-11
pubmed: 18923512
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6461-6
pubmed: 24706880
Nucleic Acids Res. 2009 Jan;37(Database issue):D832-6
pubmed: 19015121
Nat Rev Neurosci. 2010 May;11(5):316-28
pubmed: 20404840
Neuropharmacology. 2004 Oct;47(5):724-33
pubmed: 15458844
Hum Mol Genet. 2004 Jul 15;13(14):1471-7
pubmed: 15150161
Nat Cell Biol. 1999 Sep;1(5):253-9
pubmed: 10559936
Neuron. 2005 Oct 20;48(2):229-36
pubmed: 16242404
Nat Genet. 2003 May;34(1):27-9
pubmed: 12669065
Nature. 2017 Sep 28;549(7673):533-537
pubmed: 28959975
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13764-9
pubmed: 21808020
Proc Natl Acad Sci U S A. 2016 May 31;113(22):E3081-90
pubmed: 27185935
Transl Psychiatry. 2018 Mar 5;8(1):45
pubmed: 29503438
J Neurosci. 1988 Apr;8(4):1454-68
pubmed: 3282038

Auteurs

Nicholas J F Gatford (NJF)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology, & Neuroscience, King's College London, London, UK.
MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

P J Michael Deans (PJM)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology, & Neuroscience, King's College London, London, UK.
MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Rodrigo R R Duarte (RRR)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology, & Neuroscience, King's College London, London, UK.

George Chennell (G)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology, & Neuroscience, King's College London, London, UK.

Katherine J Sellers (KJ)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology, & Neuroscience, King's College London, London, UK.

Pooja Raval (P)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology, & Neuroscience, King's College London, London, UK.
MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Deepak P Srivastava (DP)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology, & Neuroscience, King's College London, London, UK.
MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH